l carnitine 3000 uses L-Carnitine | Linus Pauling Institute L-Carnitine 3000 - Green Apple

Harvey RE, Coffman KE, Miller VM

But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat

Beyond mechanical and circulatory concerns, tumorigenic and immunomodulatory risks must also be considered

reduction of protein degradation